Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA STRIDES PHARMA SCIENCE NATCO PHARMA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 13.3 -1,455.3 - View Chart
P/BV x 3.5 3.3 106.6% View Chart
Dividend Yield % 0.6 0.2 301.6%  

Financials

 NATCO PHARMA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
NATCO PHARMA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs847392 215.9%   
Low Rs502263 190.5%   
Sales per share (Unadj.) Rs148.4408.5 36.3%  
Earnings per share (Unadj.) Rs39.2-25.6 -153.3%  
Cash flow per share (Unadj.) Rs48.21.4 3,521.8%  
Dividends per share (Unadj.) Rs5.501.50 366.7%  
Avg Dividend yield %0.80.5 178.2%  
Book value per share (Unadj.) Rs267.1242.8 110.0%  
Shares outstanding (eoy) m182.4790.30 202.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.50.8 566.3%   
Avg P/E ratio x17.2-12.8 -134.2%  
P/CF ratio (eoy) x14.0239.6 5.8%  
Price / Book Value ratio x2.51.4 187.0%  
Dividend payout %14.0-5.9 -239.2%   
Avg Mkt Cap Rs m123,04929,603 415.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8677,320 66.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07136,884 73.4%  
Other income Rs m1,2851,352 95.0%   
Total revenues Rs m28,35638,236 74.2%   
Gross profit Rs m9,117830 1,098.7%  
Depreciation Rs m1,6382,433 67.3%   
Interest Rs m1452,611 5.6%   
Profit before tax Rs m8,619-2,862 -301.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,466-553 -265.1%   
Profit after tax Rs m7,153-2,309 -309.8%  
Gross profit margin %33.72.2 1,497.0%  
Effective tax rate %17.019.3 88.0%   
Net profit margin %26.4-6.3 -422.1%  
BALANCE SHEET DATA
Current assets Rs m30,00331,353 95.7%   
Current liabilities Rs m6,83129,902 22.8%   
Net working cap to sales %85.63.9 2,176.6%  
Current ratio x4.41.0 418.9%  
Inventory Days Days6371 89.2%  
Debtors Days Days115129 89.8%  
Net fixed assets Rs m26,57131,300 84.9%   
Share capital Rs m365903 40.4%   
"Free" reserves Rs m48,37321,025 230.1%   
Net worth Rs m48,73821,928 222.3%   
Long term debt Rs m011,398 0.0%   
Total assets Rs m56,57463,734 88.8%  
Interest coverage x60.4-0.1 -62,989.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.6 82.7%   
Return on assets %12.90.5 2,718.5%  
Return on equity %14.7-10.5 -139.4%  
Return on capital %18.0-0.8 -2,391.5%  
Exports to sales %046.7 0.0%   
Imports to sales %10.20-   
Exports (fob) Rs mNA17,213 0.0%   
Imports (cif) Rs m2,772NA-   
Fx inflow Rs m17,25618,113 95.3%   
Fx outflow Rs m2,772672 412.8%   
Net fx Rs m14,48417,442 83.0%   
CASH FLOW
From Operations Rs m8,491444 1,911.9%  
From Investments Rs m-4,7713,025 -157.7%  
From Financial Activity Rs m-3,630-2,139 169.7%  
Net Cashflow Rs m2081,328 15.7%  

Share Holding

Indian Promoters % 49.7 27.4 181.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 38.9 64.3%  
FIIs % 13.7 19.5 70.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 72.6 69.3%  
Shareholders   207,571 91,182 227.6%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs STRIDES PHARMA SCIENCE Share Price Performance

Period Natco Pharma STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day -2.11% 1.16% 1.18%
1-Month -3.19% 0.35% -0.75%
1-Year 72.80% 176.88% 61.82%
3-Year CAGR 4.96% -3.35% 18.16%
5-Year CAGR 10.96% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.